Hospital Vall d'Hebron-ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2023

  1. Decoding the molecular heterogeneity of pediatric monomorphic post–solid organ transplant lymphoproliferative disorders

    Blood, Vol. 142, Núm. 5, pp. 434-445

2022

  1. Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications

    Histopathology, Vol. 81, Núm. 6, pp. 826-840

2021

  1. Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma

    Nature Communications, Vol. 12, Núm. 1

2013

  1. MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma

    British Journal of Haematology, Vol. 162, Núm. 3, pp. 336-347

2011

  1. Improved demonstration of immunohistochemical prognostic markers for survival in follicular lymphoma cells

    Modern Pathology, Vol. 24, Núm. 5, pp. 698-707

2010

  1. Aggressive large B-cell lymphoma with plasma cell differentiation: Immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype

    Haematologica, Vol. 95, Núm. 8, pp. 1342-1349

  2. Amolecular risk score based on 4 functional pathways for advanced classical Hodgkin lymphoma

    Blood, Vol. 116, Núm. 8

2008

  1. Erratum: Frequency of BCL2 and BCL6 translocations in follicular lymphoma: Relation with histological and clinical features (Leukemia and Lymphoma (2008) vol. 49(1) (95-101))

    Leukemia and Lymphoma